01
Cash & equivalents increased 35.7%
Cash & equivalents changed +35.7% from the comparable as-filed period.
$30.3M→$41.1MComparable → current
· Services-Offices & Clinics of Doctors of Medicine
RESEARCH SNAPSHOTStarling Oncology, Inc.'s latest supported as-filed period reports revenue of $161.3M, 34.6% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +35.7% from the comparable as-filed period.
Inventory changed +26.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +42.4% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
STLN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001079973-26-001175SEC ↗8-KAug 21, 2026Period Aug 20, 20260001079973-26-001169SEC ↗4Aug 17, 2026Period Aug 13, 20260000921895-26-002203SEC ↗10-QAug 6, 2026Period Jun 30, 20260001799191-26-000017SEC ↗8-KAug 6, 2026Period Aug 6, 20260001079973-26-001006SEC ↗8-KAug 3, 2026Period Jul 28, 20260001079973-26-000997SEC ↗4Jul 29, 2026Period Jul 27, 20260001079973-26-000993SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 21, 2026Filed Aug 24, 2026 | Hively BradDirector | Open Market SaleDirect | 298,853 | $7 | $1.9M | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating income changed +58.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +650 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed +34.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Selling, general & administrative changed +11.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001079973-26-000991